Literature DB >> 21135485

Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results.

E M Jung1, C J Ross, J Rennert, M N Scherer, S Farkas, P von Breitenbuch, A A Schnitzbauer, P Piso, P Lamby, C Menzel, A G Schreyer, S Feuerbach, H J Schlitt, M Loss.   

Abstract

AIM: Evaluation of high resolution linear ultrasound and intra-operative linear contrast enhanced ultrasound (CEUS) and its benefit for the detection and characterization of tumor lesions.
MATERIAL AND METHODS: Twenty patients were investigated preoperatively regarding tumor detection using CT (n = 8) or MRI (n = 12) and image fusion (VNav) (n = 3). All patients had surgery for their hepatic tumor (hepatocellular carcinoma (HCC), cholangiocellular carcinoma (CCC), metastasis, and adenoma). Ultrasound was performed intra-operatively first with B-scan using a convex probe. Than multifrequency linear transmitters (6-9 MHz, 6-15 MHz, LOGIQ E9, GE) were applied for B-scan, coulor coded Doppler sonography (CCDS) and Power Doppler followed by dynamic CEUS with Contrast Harmonic Imaging (CHI) after bolus injection of a maximum of 15 mL SonoVue®.
RESULTS: In 9 cases with the use of intra-operative CEUS additional tumor lesions (diameter 4-15 mm) could be detected and were histologically confirmed after surgical resection (7 cases) or intra-operative biopsy (2 cases). Using intraoperative CEUS 64 tumor lesions could be detected compared to 51 tumor lesions detected by preoperative CT or MRI (p < 0.05). Using the 6-15 MHz multifrequency linear transducer with CHI, arterial perfusion of adenomas, neuroendocrine metastases and HCC lesions was detectable. In 3 cases a resection was not achievable. Two of these cases were treated with radio frequency ablation (RFA). The other case had no curable option due to multifocal tumor manifestation.
CONCLUSION: The intra-operative use of high-resolution linear transducer techniques with CEUS offers new diagnostic perspectives for an effective liver surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135485     DOI: 10.3233/CH-2010-1336

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  10 in total

Review 1.  [Possibilities of sonographic image fusion: Current developments].

Authors:  E M Jung; D-A Clevert
Journal:  Radiologe       Date:  2015-11       Impact factor: 0.635

2.  Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancement.

Authors:  Qiong Wu; Yan Wang; Yi Li; Bing Hu; Zhi-Yan He
Journal:  Endocrine       Date:  2016-01-05       Impact factor: 3.633

3.  [Interventional sonography of the liver and kidneys].

Authors:  D-A Clevert; E M Jung
Journal:  Radiologe       Date:  2013-11       Impact factor: 0.635

4.  Early prediction of response of sorafenib on hepatocellular carcinoma by CT perfusion imaging: an animal study.

Authors:  Q Wang; G Shi; L Wang; X Liu; R Wu
Journal:  Br J Radiol       Date:  2014-01-27       Impact factor: 3.039

5.  [Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma].

Authors:  E M Jung; W Uller; C Stroszczynski; D-A Clevert
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

Review 6.  [Role of the radiologist in surgery of colorectal liver metastases : What should be removed and what must remain].

Authors:  J Strohäker; A Königsrainer; S Nadalin
Journal:  Radiologe       Date:  2019-09       Impact factor: 0.635

7.  Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.

Authors:  Liliana Chiorean; Adrian Bartos; Doris Pelau; Dana Iancu; Tudor Ciuleanu; Rares Buiga; Irinel Oancea; Angelica Mangrau; Cornel Iancu; Radu Badea
Journal:  J Med Ultrason (2001)       Date:  2014-10-25       Impact factor: 1.314

Review 8.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28

9.  Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility.

Authors:  Hwaseong Ryu; Jung Hoon Kim; Seunghyun Lee; Joon Koo Han
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

10.  Assessment of Renal Transplant Perfusion by Contrast-Enhanced Ultrasound after Switch from Calcineurin Inhibitor to Belatacept: A Pilot Study.

Authors:  Bilgin Osmanodja; Frédéric Muench; Alexander Holderied; Klemens Budde; Thomas Fischer; Markus Herbert Lerchbaumer
Journal:  J Clin Med       Date:  2022-07-27       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.